CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

The LAVA Study, which stands for Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S.

Data presented in two abstracts at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting.

The initial results of the first 160 treated women in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE) show the broad applicability of Transcervical Fibroid Ablation performed by the Sonata System to a wide range of fibroid types and sizes while maintaining an excellent safety profile.

The article is an analysis of a subgroup of patients with submucous or large fibroids from two previously published multicenter prospective clinical trials (FAST-EU and SONATA) of transcervical fibroid ablation (TFA) with the Sonata System.

Both companies are ideally positioned to leverage shared resources to accelerate the initiation of the U.S. clinical trial of the SeQuent Please ReX to study the treatment of coronary in-stent restenosis (ISR), which is defined as the gradual re-narrowing of a coronary artery following stent implantation.

Pivotal study to evaluate the use of novel liquid embolic versus standard of care in treating malignant and benign hypervascular tumors.

The first adjustable, fully visible stent retriever shows superiority over conventional stent retrievers in a multicenter trial. The late-breaking results were recently presented at the International Stroke Conference and published online in the journal Stroke.

The study will assess the duration of response (DoR) and objective response rate (ORR) of SIR-Spheres.